Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region
Histopathology · 2025-08 · 87 (2) · 270-283
DOI: 10.1111/his.15456 ↗Kurz gefasst
Fachartikel in der Zeitschrift Histopathology, online erschienen am 15.04.2025. Verfasst von Costantino Ricci und 20 weiteren Autor:innen. Beteiligte Einrichtung: Pathology Unit, DIAP-Dipartimento Interaziendale di anatomia patologica di Bologna, Maggiore Hospital-AUSL, Bologna, Bologna, Italy. Hauptthemen laut MEDLINE: Melanoma, Head and Neck Neoplasms. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 37 Literaturangaben.
Abstract (Originalsprache)
Aims
Mucosal melanoma of the head and neck (MM–H&N) is an aggressive disease known for its frequent residual tumours/relapses (RT/R) at the surgical site, as well as eventual metastases. Our understanding of the MM–H&N mutational landscape, together with the correlation of specific mutations with clinical–pathological features, is significantly less comprehensive compared to that of cutaneous melanoma. Additionally, the mutational status of consecutive samples collected from single patients has not been investigated, which limits our ability to characterise the prognosis and treatment options for this patient subset. Methods and results A total of 53 MM–H&N specimens from 27 patients were analysed using a laboratory‐developed multigene next‐generation sequencing (NGS) panel. Among these, material from 46 of 53 (86.8%) samples and from 25 of 27 patients (92.6%) was suitable for NGS. The most frequently detected mutations were found in the RAS genes family, specifically KRAS and NRAS (seven of 46, 15.2%), as well as TP53 , KIT and BRAF (each in three of 46, 6.5%); 25 of 46 (54.3%) samples exhibited a wild‐type (WT) status. A statistically significant association between BRAF / RAS mutations and mucosal lentiginous histology ( P = 0.041) was observed. Additionally, four of 11 (36.4%) patients with consecutive specimens, with no pre‐/intersurgery systemic therapies administered and all having at least two evaluable NGS results, demonstrated molecular heterogeneity in the analysed samples.
Conclusions
MM–H&N shows a significant percentage of WT cases and a limited number of targetable mutations, predominantly involving BRAF/RAS mutations, the latter of which are associated with mucosal lentiginous histology. A subset of patients with consecutive samples demonstrates discordant molecular results, indicating that NGS of all samples may be necessary to determine the most appropriate therapeutic approach.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathology Unit, DIAP-Dipartimento Interaziendale di anatomia patologica di Bologna, Maggiore Hospital-AUSL, Bologna, Bologna, Italy.
- Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- School of Anatomic Pathology, Department of Biomedical and Neuromotor Sciences (DIBINEM), University of Bologna, Bologna, Italy.
- Solid Tumor Molecular Pathology Laboratory, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.
- Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
- ENT Unit, Surgical Department, Bellaria Hospital, University of Bologna, Bologna, Italy.
ORCID-Profile: Costantino Ricci, Dario de Biase, Barbara Corti, Ernesto Pasquini, Gabriele Molteni, Achille Tarsitano, Anna Maria Baietti, Luca Amorosa, Francesca Ambrosi, Tiziana Balbi, Chiara Baldovini, Giulia Querzoli, Antonia D'Errico, Michelangelo Fiorentino, Giovanni Tallini, Antonio De Leo, Thais Maloberti, Daniela Massi, Stephan Ihrler, Maria Pia Foschini
Zitieren
APA
Ricci, C., Altavilla, M. V., de Biase, D., Corti, B., Pasquini, E., Molteni, G., Tarsitano, A., Baietti, A. M., Amorosa, L., Ambrosi, F., Balbi, T., Baldovini, C., Querzoli, G., D'Errico, A., Fiorentino, M., Tallini, G., De Leo, A., Maloberti, T., Massi, D., …, & Foschini, M. P. (2025). Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region. Histopathology, 87(2), 270-283. https://doi.org/10.1111/his.15456
Vancouver
Ricci C, Altavilla MV, de Biase D, Corti B, Pasquini E, Molteni G, et al. Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region. Histopathology. 2025;87(2):270-283. doi:10.1111/his.15456
BibTeX
@article{Ricci2025,
author = {Ricci, Costantino and Altavilla, Maria Vittoria and de Biase, Dario and Corti, Barbara and Pasquini, Ernesto and Molteni, Gabriele and Tarsitano, Achille and Baietti, Anna Maria and Amorosa, Luca and Ambrosi, Francesca and Balbi, Tiziana and Baldovini, Chiara and Querzoli, Giulia and D'Errico, Antonia and Fiorentino, Michelangelo and Tallini, Giovanni and De Leo, Antonio and Maloberti, Thais and Massi, Daniela and Ihrler, Stephan and Foschini, Maria Pia},
title = {Unveiling the molecular landscape and clinically relevant molecular heterogeneity of mucosal melanoma of the head and neck region},
journal = {Histopathology},
year = {2025},
volume = {87},
number = {2},
pages = {270--283},
doi = {10.1111/his.15456}
}
EUVIMED